Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÁøÇàµÈ ¾ÏȯÀÚ¿¡¼­ »óºÎ¿ä·Î Æó»öÀÇ ³»ºñ´¢±â°úÀû Ä¡·á Endourologic Treatment of the Upper Urinary Tract Obsturction in the Advanced Cancer Patients

´ëÇѺñ´¢±â°úÇÐȸÁö 1996³â 37±Ç 3È£ p.301 ~ 307
¾ÈÀçõ, È«±ââ, ¹Ú¼ºÈñ,
¼Ò¼Ó »ó¼¼Á¤º¸
¾ÈÀçõ (  ) 
°í½Å´ëÇб³

È«±ââ (  ) 
°í½Å´ëÇб³
¹Ú¼ºÈñ (  ) 
°í½Å´ëÇб³

Abstract


Palliative endourologic treatment was done in 94 cases for ureteral obstruction secondary to advanced malignancy. The average survival was 4.2 months. The obstruction were caused by metastases or invasion of cancer in all patients. First we tried
to
insert a double J stent(STENT), when it failed percutaneous nephrostomy(PCN) was performed. Initially 16 patients were treated by STENT and 78 patients by PCN. The STENT was changed 2.2 times on the average in all patients. 75% of the patients
who
had
been treated by STENT experienced only one or two times of STENT changes before dying. Patency period of the STENT was 56.7 days on the average. The patency period was shorter in the patients who showed gross hematuria at the time of STENT
insertion.
Although survival was not so long, 60.6% patients were able to return to their homes. The endourologic management of the upper urinary tract obstruction will play a more important role and offer a better quality of life for end end stage cnacer
patients.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS